← Leaderboards
Deborah Merke
Eunice Kennedy Shriver National Institute Of Child Health & Human Development
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Eunice Kennedy Shriver National Institute Of Child Health & Human Development
Same institution · by research overlap
Others in their field
Top investigators on “Androgens”
- Shalendar Bhasin · La Biomed Res Inst/ Harbor Ucla Med Ctr$36,153,267
- Charles L Sawyers · Sloan-Kettering Inst Can Research$24,511,314
- Susan E. Hankinson · University Of Massachusetts Amherst$24,278,267
- Brian E Henderson · University Of Southern California$20,677,861
- Cory Abate-Shen · Columbia University Health Sciences$20,094,849
- Diane E Merry · Thomas Jefferson University$17,810,180
Research focus
AndrogensGrowthDesignAdultCongenital Adrenal HyperplasiaSteroid 21-MonooxygenaseAdrenal Gland HypofunctionEnrollmentFutureHydrocortisoneAdrenal GlandsGlucocorticoidsChildhoodAldosteroneCircadian RhythmsHormone Replacement TherapyAdrenal Cortex DiseasesMeasurementGrowth And Development FunctionInfertilityMetabolic SyndromeDexamethasoneMaleObesity
Grant awards (26)
Natural History Study of Patients with Excess Androgen$69,240
ZIA · FY2021 · HD · contact PI
Study of a corticotropin releasing factor-1 receptor antagonist for the treatment of congenital adrenal hyperplasia$4,073
ZIA · FY2021 · HD · contact PI
Novel treatment approaches: sex steroid blockade in children$4,073
ZIA · FY2021 · HD · contact PI
Modified-release Hydrocortisone Therapy as a Treatment for CAH$4,073
ZIA · FY2021 · HD · contact PI
Natural History Study of Patients with Excess Androgen$33,592
ZIA · FY2020 · HD · contact PI
Modified-release Hydrocortisone Therapy as a Treatment for CAH$1,976
ZIA · FY2020 · HD · contact PI
Study of a corticotropin releasing factor-1 receptor antagonist for the treatment of congenital adrenal hyperplasia$1,976
ZIA · FY2020 · HD · contact PI
Novel treatment approaches: sex steroid blockade in children$1,976
ZIA · FY2020 · HD · contact PI
Natural History Study of Patients with Excess Androgen$18,703
ZIA · FY2019 · HD · contact PI
Continuous Subcutaneous Hydrocortisone Infusion Treatment for CAH$2,201
ZIA · FY2019 · HD · contact PI
Novel treatment approaches: sex steroid blockade in children$1,100
ZIA · FY2019 · HD · contact PI
Natural History Study of Patients with Excess Androgen$17,743
ZIA · FY2018 · HD · contact PI
Continuous Subcutaneous Hydrocortisone Infusion Treatment for CAH$1,971
ZIA · FY2018 · HD · contact PI
Natural History Study of Patients with Excess Androgen$19,761
ZIA · FY2017 · HD · contact PI
Continuous Subcutaneous Hydrocortisone Infusion Treatment for CAH$2,196
ZIA · FY2017 · HD · contact PI
Modified-release Hydrocortisone Therapy as a Treatment for CAH$1
ZIA · FY2017 · HD · contact PI
Natural History Study of Patients with Excess Androgen$20,353
ZIA · FY2016 · HD · contact PI
Continuous Subcutaneous Hydrocortisone Infusion Treatment for CAH$2,262
ZIA · FY2016 · HD · contact PI
Natural History Study of Patients with Excess Androgen$13,771
ZIA · FY2015 · HD · contact PI
Continuous Subcutaneous Hydrocortisone Infusion Treatment for CAH$5,902
ZIA · FY2015 · HD · contact PI
Modified-release Hydrocortisone Therapy as a Treatment for CAH$1
ZIA · FY2015 · HD · contact PI
Natural History Study of Patients with Excess Androgen$24,703
ZIA · FY2014 · HD · contact PI
Continuous Subcutaneous Hydrocortisone Infusion Treatment for CAH$10,587
ZIA · FY2014 · HD · contact PI
Modified-release Hydrocortisone Therapy as a Treatment for CAH$1
ZIA · FY2014 · HD · contact PI
Natural History Study of Patients with Excess Androgen$19,923
ZIA · FY2013 · HD · contact PI
Continuous Subcutaneous Hydrocortisone Infusion Treatment for CAH$8,539
ZIA · FY2013 · HD · contact PI